Phase 2 Trial of LDE225 and Lenalidomide Maintenance Post Autologous Stem Cell Transplant for Multiple Myeloma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 10 Apr 2018
At a glance
- Drugs Lenalidomide (Primary) ; Sonidegib (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 03 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 12 Oct 2017 Planned End Date changed from 1 Aug 2017 to 1 Aug 2018.
- 12 Oct 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Aug 2018.